Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Bookman · SciRah

Researcher profile · Semantic Scholar

M. Bookman

Share profile

M. Bookman — researcher profile on SciRah

h-index: 59
Works: 268
Citations: 18K

Most-cited papers

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
D. Bowtell, Steffen Böhm, A. A. Ahmed, P. Aspuria +37 more
2015Nature Reviews. Cancer1,092 citations Open access
Semantic Scholar
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer
R. Coleman, G. Fleming, M. Brady, E. Swisher +28 more
2019New England Journal of Medicine749 citations Open access
Semantic Scholar
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline
A. Wright, K. Bohlke, D. Armstrong, M. Bookman +13 more
2016Journal of Clinical Oncology564 citations Open access
Semantic Scholar
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)
K. Moore, M. Bookman, J. Sehouli, Austin Miller +24 more
2021Journal of Clinical Oncology338 citations Open access
Semantic Scholar
PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline
W. Tew, C. Lacchetti, Annie E. Ellis, Kathleen Maxian +12 more
2020Journal of Clinical Oncology247 citations Open access
Semantic Scholar
Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182.
Neil S. Horowitz, Austin Miller, B. Rungruang, S. Richard +5 more
2015Journal of Clinical Oncology240 citations Open access
Semantic Scholar
Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer.
A. Wright, A. Cronin, Dana Milne, M. Bookman +12 more
2015Journal of Clinical Oncology176 citations Open access
Semantic Scholar
Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer.
L. Meyer, A. Cronin, Charlotte C. Sun, K. Bixel +10 more
2016Journal of Clinical Oncology135 citations Open access
Semantic Scholar
Optimal primary therapy of ovarian cancer.
M. Bookman
2016Annals of Oncology99 citations Open access
Semantic Scholar
An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience
Kate E. Oliver, W. Brady, M. Birrer, D. Gershenson +15 more
2017Gynecologic Oncology92 citations Open access
Semantic Scholar
Risk factors for GI adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: A Gynecologic Oncology Group Study.
R. Burger, M. Brady, M. Bookman, B. Monk +10 more
2014Journal of Clinical Oncology85 citations Open access
Semantic Scholar
Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study
J. Ferriss, J. Java, M. Bookman, G. Fleming +7 more
2015Gynecologic Oncology80 citations Open access
Semantic Scholar
Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial
Joyce F. Liu, M. Brady, U. Matulonis, Austin Miller +17 more
2022Journal of Clinical Oncology79 citations Open access
Semantic Scholar
Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (KELIM): The GOG-0218 Validation Study
B. You, C. Purdy, L. Copeland, E. Swisher +16 more
2022Journal of Clinical Oncology68 citations Open access
Semantic Scholar
Fifth Ovarian Cancer Consensus Conference: individualized therapy and patient factors.
J. Mcgee, M. Bookman, P. Harter, C. Marth +18 more
2017Annals of Oncology60 citations Open access
Semantic Scholar
Use of CA-125 Tests and CT Scans for Surveillance in Ovarian Cancer
K. Esselen, A. Cronin, K. Bixel, M. Bookman +12 more
2016JAMA Oncology51 citations Open access
Semantic Scholar
Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma
P. Rose, J. Java, R. Salani, M. Geller +17 more
2019Obstetrics and Gynecology43 citations Open access
Semantic Scholar
Chemotherapy-induced neutropenia as a biomarker of survival in advanced ovarian carcinoma: an exploratory study of the gynecologic oncology group.
K. Tewari, J. Java, T. Gatcliffe, M. Bookman +1 more
2014Gynecologic Oncology43 citations Open access
Semantic Scholar
A phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer.
Joyce F. Liu, M. Brady, U. Matulonis, Austin Miller +16 more
202042 citations
Semantic Scholar
Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial
C. Landen, L. Molinero, H. Hamidi, J. Sehouli +20 more
2023Clinical Cancer Research41 citations Open access
Semantic Scholar
Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study
C. Hamilton, Austin Miller, Y. Casablanca, N. Horowitz +13 more
2017Gynecologic Oncology41 citations Open access
Semantic Scholar
Harmonising clinical trials within the Gynecologic Cancer InterGroup: consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference
M. Bookman, A. Okamoto, G. Stuart, N. Yanaihara +10 more
2017Annals of Oncology40 citations Open access
Semantic Scholar
CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 Study
B. You, Vasudha Sehgal, B. Hosmane, Xin Huang +11 more
2022Journal of Clinical Oncology39 citations Open access
Semantic Scholar
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline
A. Wright, K. Bohlke, D. Armstrong, M. Bookman +13 more
2016Gynecologic Oncology38 citations Open access
Semantic Scholar
Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study.
E. Swisher, C. Aghajanian, D. O'Malley, G. Fleming +15 more
2021Gynecologic Oncology37 citations Open access
Semantic Scholar
Final overall survival (OS) analysis of an international randomized trial evaluating bevacizumab (BEV) in the primary treatment of advanced ovarian cancer: A NRG oncology/Gynecologic Oncology Group (GOG) study.
R. Burger, Danielle M. Enserro, K. Tewari, M. Brady +14 more
201837 citations
Semantic Scholar
Second-line olaparib maintenance therapy is associated with poor response to subsequent chemotherapy in BRCA1/2-mutated epithelial ovarian cancer: A multicentre retrospective study.
Junsik Park, S. I. Kim, S. Jeong, Yup Kim +4 more
2022Gynecologic Oncology34 citations Open access
Semantic Scholar
LBA31 Primary results from IMagyn050/GOG 3015/ENGOT-OV39, a double-blind placebo (pbo)-controlled randomised phase III trial of bevacizumab (bev)-containing therapy +/- atezolizumab (atezo) for newly diagnosed stage III/IV ovarian cancer (OC)
K. Moore, M. Bookman, J. Sehouli, A. Miller +16 more
202034 citations Open access
Semantic Scholar
Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients
K. Fuh, J. Java, J. Chan, D. Kapp +12 more
2019Gynecologic Oncology32 citations Open access
Semantic Scholar
Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
C. Creutzberg, Jae-Weon Kim, G. Eminowicz, Emma R. Allanson +26 more
2024The Lancet Oncology31 citations Open access
Semantic Scholar
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer
S. Pignata, M. Bookman, J. Sehouli, A. Miller +21 more
2023Gynecologic Oncology31 citations
Semantic Scholar
Phase 1b study of AVB-500 in combination with paclitaxel or pegylated liposomal doxorubicin platinum-resistant recurrent ovarian cancer.
K. Fuh, M. Bookman, Joyce F. Liu, R. Coleman +7 more
2021Gynecologic Oncology29 citations Open access
Semantic Scholar
Outcomes of secondary cytoreductive surgery for patients with platinum-sensitive recurrent ovarian cancer.
A. Gockley, Alexander Melamed, A. Cronin, M. Bookman +9 more
2019American Journal of Obstetrics and Gynecology26 citations
Semantic Scholar
Impact of primary platinum-free interval and BRCA1/2 mutation status on treatment and survival in patients with recurrent ovarian cancer.
M. Bookman, J. Tyczynski, J. Espirito, Thomas W. Wilson +1 more
2017Gynecologic Oncology26 citations
Semantic Scholar
Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference
J. A. Jang, N. Yanaihara, E. Pujade-Lauraine, Y. Mikami +15 more
2017Journal of Gynecologic Oncology26 citations Open access
Semantic Scholar
PHASE I and Randomized Phase II STUDY OF RUXOLITINIB WITH FRONT-LINE NEOADJUVANT THERAPY IN ADVANCED OVARIAN CANCER: An NRG Oncology Group Study
Charles N. Landen, Ronald J. Buckanovich, M. Sill, R. Mannel +14 more
2024Journal of Clinical Oncology24 citations
Semantic Scholar
Does Adjuvant Chemotherapy Dose Modification Have an Impact On the Outcome of Patients diagnosed with Advanced Stage Ovarian Cancer? An NRG Oncology/Gynecologic Oncology Group Study
A. Olawaiye, J. Java, T. Krivak, M. Friedlander +9 more
2018Gynecologic Oncology23 citations Open access
Semantic Scholar
CT perfusion as an early biomarker of treatment efficacy in advanced ovarian cancer: an ACRIN and GOG study
C. Ng, Zheng Zhang, Susanna I. Lee, H. Marques +13 more
2017Clinical Cancer Research22 citations Open access
Semantic Scholar
Predictive Modeling for Determination of Microscopic Residual Disease at Primary Cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study
N. Horowitz, G. L. Maxwell, Austin Miller, C. Hamilton +14 more
2017Gynecologic Oncology20 citations Open access
Semantic Scholar
Evolving Concepts in the Management of Newly Diagnosed Epithelial Ovarian Cancer.
C. Gourley, M. Bookman
2019Journal of Clinical Oncology18 citations Open access
Semantic Scholar
CamGFR v2: a new model for estimating the glomerular filtration rate from standardized or non-standardized creatinine in patients with cancer
E. Williams, T. R. Flint, C. Connell, D. Giglio +12 more
2020Clinical Cancer Research15 citations Open access
Semantic Scholar
Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer – an ancillary data analysis of the VELIA trial
C. Aghajanian, E. Swisher, A. Okamoto, K. Steffensen +12 more
2021Gynecologic Oncology13 citations Open access
Semantic Scholar
What is the Role of Retroperitoneal Exploration in Optimally Debulked Stage IIIC Epithelial Ovarian Cancer?: An NRG Oncology/Gynecologic Oncology Group Ancillary Data Study
Bunja J. Rungruang, Austin Miller, T. Krivak, Neil S. Horowitz +12 more
2016Cancer13 citations Open access
Semantic Scholar
Joint ENGOT and GOG Foundation requirements for trials with industry partners
I. Vergote, R. Coleman, S. Pignata, M. Bookman +4 more
2019International Journal of Gynecological Cancer12 citations Open access
Semantic Scholar
Intraperitoneal chemotherapy: long-term outcomes revive a long-running debate.
M. Bookman, M. Brady
2015Journal of Clinical Oncology12 citations Open access
Semantic Scholar
36 Prognostic value and association with veliparib benefit of modeled CA-125 elimination kinetics (KELIM) in patients with newly diagnosed ovarian cancer: analysis from the VELIA/GOG-3005 study
B. You, G. Fleming, M. Bookman, K. Moore +2 more
202011 citations Open access
Semantic Scholar
The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary study
Tiffany Y. Sia, W. Tew, C. Purdy, D. Chi +17 more
2023Gynecologic Oncology10 citations Open access
Semantic Scholar
Joint ENGOT and GOG Foundation requirements for trials with industry partners.
I. Vergote, R. Coleman, S. Pignata, M. Bookman +4 more
2019Gynecologic Oncology10 citations
Semantic Scholar
VELIA/GOG-3005: Integration of veliparib (V) with front-line chemotherapy and maintenance in women with high-grade serous carcinoma of ovarian, fallopian tube, or primary peritoneal origin (HGSC)
R. Coleman, G. Fleming, M. Brady, E. Swisher +16 more
2019Annals of Oncology10 citations Open access
Semantic Scholar
Sister Society Meeting on Global Education Development and Collaboration: Meeting Report
L. Chuang, Thomas C. Randall, L. Denny, C. Johnston +22 more
2016International Journal of Gynecologic Cancer10 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

K. Moore×13
Invite
K. Moore — researcher profile on SciRah
R. Coleman×11
Invite
R. Coleman — researcher profile on SciRah
G. Fleming×11
Invite
G. Fleming — researcher profile on SciRah
R. Burger×11
Invite
R. Burger — researcher profile on SciRah

×10

Invite

C. Aghajanian — researcher profile on SciRah

Invite

K. Tewari — researcher profile on SciRah

Invite

E. Swisher — researcher profile on SciRah

Invite

A. Okamoto — researcher profile on SciRah

Austin Miller×8

Invite

Austin Miller — researcher profile on SciRah

Invite

M. Brady — researcher profile on SciRah

Invite

D. O'Malley — researcher profile on SciRah

Invite

L. Copeland — researcher profile on SciRah